Total Payments
$9,005
2024 Payments
$3,420
Companies
30
Transactions
404
Medicare Patients
4,504
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$9,005 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,005 | 404 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,599 | 75 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $972.65 | 39 | $0 (2024) |
| LEO Pharma Inc. | $856.41 | 35 | $0 (2024) |
| GENZYME CORPORATION | $804.57 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $677.23 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $607.70 | 25 | $0 (2024) |
| UCB, Inc. | $451.28 | 24 | $0 (2024) |
| Galderma Laboratories, L.P. | $394.40 | 18 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $388.84 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $340.15 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,420 | 154 | ABBVIE INC. ($437.59) |
| 2023 | $1,967 | 94 | ABBVIE INC. ($353.20) |
| 2022 | $1,466 | 74 | ABBVIE INC. ($284.78) |
| 2021 | $987.21 | 52 | AbbVie Inc. ($216.26) |
| 2020 | $147.02 | 8 | MAYNE PHARMA INC. ($24.71) |
| 2019 | $421.31 | 15 | AbbVie, Inc. ($188.34) |
| 2018 | $476.12 | 6 | Amgen Inc. ($125.00) |
| 2017 | $119.07 | 1 | AbbVie, Inc. ($119.07) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Immunology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.97 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Immunology | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Immunology | ||||||
| 11/24/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.28 | General |
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.77 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Kerecis Limited | Kerecis Omega3 SurgiClose (Device), Kerecis Omega3 Marigen, Kerecis Omega3 Marigen | Food and Beverage | Cash or cash equivalent | $51.16 | General |
| Category: Wound Care | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Immunology | ||||||
| 11/05/2024 | PFIZER INC. | LITFULO (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,515 | 2,264 | $948,295 | $312,668 |
| 2022 | 20 | 1,075 | 1,609 | $770,074 | $254,955 |
| 2021 | 21 | 1,272 | 1,941 | $865,361 | $295,515 |
| 2020 | 16 | 642 | 1,047 | $477,532 | $166,634 |
Total Patients
4,504
Total Services
6,861
Medicare Billing
$1.0M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 163 | 211 | $294,345 | $94,515 | 32.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 54 | 67 | $87,837 | $33,617 | 38.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 66 | 95 | $80,750 | $31,661 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 285 | 445 | $82,770 | $28,077 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 253 | $64,009 | $24,174 | 37.8% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 26 | 28 | $43,848 | $16,911 | 38.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 73 | 80 | $79,280 | $15,672 | 19.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 119 | 149 | $32,333 | $10,354 | 32.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 95 | 119 | $28,084 | $9,489 | 33.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 46 | 48 | $30,672 | $8,674 | 28.3% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 12 | 12 | $22,596 | $8,642 | 38.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 116 | 148 | $20,128 | $5,967 | 29.6% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 16 | 18 | $14,634 | $5,838 | 39.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $12,996 | $4,546 | 35.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 18 | 23 | $20,677 | $4,022 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $12,240 | $3,939 | 32.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 74 | 371 | $5,194 | $1,918 | 36.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 26 | 36 | $3,960 | $1,460 | 36.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 11 | 11 | $6,380 | $1,371 | 21.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $2,970 | $1,140 | 38.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 15 | 18 | $2,088 | $655.10 | 31.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 28 | $504.00 | $23.90 | 4.7% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 151 | 200 | $279,000 | $92,839 | 33.3% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 68 | 96 | $81,600 | $31,921 | 39.1% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 44 | 55 | $72,105 | $25,050 | 34.7% |
About Dr. Meredith Orseth, M.D
Dr. Meredith Orseth, M.D is a Dermatology healthcare provider based in Cedar Hill, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1598178568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Meredith Orseth, M.D has received a total of $9,005 in payments from pharmaceutical and medical device companies, with $3,420 received in 2024. These payments were reported across 404 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($9,005).
As a Medicare-enrolled provider, Orseth has provided services to 4,504 Medicare beneficiaries, totaling 6,861 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery
- Location Cedar Hill, TX
- Active Since 06/08/2014
- Last Updated 07/29/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1598178568
Products in Payments
- DUPIXENT (Biological) $1,603
- ADBRY (Biological) $699.97
- TREMFYA (Drug) $649.83
- SKYRIZI (Biological) $558.07
- RINVOQ (Biological) $481.48
- COSENTYX (Drug) $355.57
- Sotyktu (Drug) $340.15
- Bimzelx (Biological) $268.52
- TALTZ (Drug) $266.81
- COSENTYX (Biological) $252.13
- SILIQ (Drug) $214.37
- HUMIRA (Biological) $204.03
- VTAMA (Drug) $198.54
- OPZELURA (Drug) $187.35
- Cimzia (Drug) $182.76
- Humira (Biological) $160.67
- ENSTILAR (Drug) $156.44
- Skyrizi (Biological) $146.74
- Enbrel (Biological) $140.42
- EUCRISA (Drug) $126.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.